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t(16;21)(p11;q22) has been found in rare cases of 
Ewing tumours, a paediatric neoplasm with small 
round-cells derived from neural crests cells usually 
associated with translocations involving EWSR1. 
Cytogenetics 
Ewing tumours are usually associated with a 
t(11;22)(q24;q12) with 5' EWSR1 - 3' FLI1 
involvement, less often associated with 
t(21;22)(q22;q12) with 5' EWSR1 - 3' ERG 
involvement, rarely associated with t(2;22)(q36; q12) 
(5' EWSR1 - 3' FEV) or with t(17;22)(q21;q12) (5' 
EWSR1-3' ETV4). 
Prognosis 
Recent treatments have improved the prognosis of 
Ewing's tumours. The prognosis is mainly determined 
by the presence of metastases at the time of diagnosis. 
 
Disease 
de novo acute non lymphocytic leukemia (ANLL); to 
be noted is one case of chronic myelogenous leukemia 
(CML) -blast crisis. 
Phenotype / cell stem origin 
ANLL cases: mainly M1, M2, M4, M5a, M5b, or M7 
ANLL; may be preceded by a myelodysplastic 
syndrome (MDS). 
Epidemiology 
About 40 reported cases, mainly found in young adults; 
children cases are described; median age is about 30 
yrs; balanced sex ratio. 
Clinics 
Blood data: anemia, thrombocytopenia, mild 
hyperleucocytosis; with high monocytic cell count at 
times. 
Cytology 
Myelocytic and monocytoid features are often present; 
eosinophils in the bone marrow are sometimes 
abnormal and/or elevated; erythrophagocytosis may be 
found. 
Prognosis 
Seems poor: complete remission may not be achieved; 
there is high incidence of relapse within a year and  




ANLL cases: found solely in about 60% of cases in at 
least a subclone; associated with +10, +8, or de(9q)/-9 
in about 10% of cases each. 
























ETS transcription factor. 




5' FUS including exons 1 to 6, 7 or 8 - 3' ERG from 
exon 7, 8 or 9 to C-term. 
Fusion Protein 
Description 
N-term FUS transactivation domain fused to the C-term 
DNA binding ETS domain of ERG. 
Oncogenesis 
Seems to act as a transcriptional activator. 
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